The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
about
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundMolecular Pathogenesis of NASHGenetic predisposition in nonalcoholic fatty liver disease.The Association between Pediatric NAFLD and Common Genetic Variants.MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.Mutations in MBOAT7, Encoding Lysophosphatidylinositol Acyltransferase I, Lead to Intellectual Disability Accompanied by Epilepsy and Autistic Features.A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Genetic and hormonal control of hepatic steatosis in female and male mice.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.Lipid droplets and liver disease: from basic biology to clinical implications.Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.Nonalcoholic fatty liver disease: Evolving paradigms.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population.Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals.The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Influence of dietary macronutrients on liver fat accumulation and metabolism.Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.Association of MBOAT7 gene variant with plasma ALT levels in children: the PANIC study.NAFLD risk alleles in PNPLA3, TM6SF2, GCKR, and LYPLAL1 show divergent metabolic effects.Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease.Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease.Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study.Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist.Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaA Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis
P2860
Q26744380-98CCAAB5-B929-48E4-8890-CF20AADBBACFQ28071265-8E676D4B-7753-40D9-BA3E-2FE472504080Q30235398-29857BD5-5008-4CE2-97F7-4E7785215250Q33831722-F999BC5B-F69B-4140-A13E-166AA49F64E2Q33866766-28BCD8BB-14DC-4263-80BD-79EB0BEEF880Q36952218-A9F902FB-3F43-4495-A0DF-F175D8FBEE84Q37264708-85B3374D-7F25-47B6-94C4-86AB5827EB78Q37342009-E6CCA895-2EE5-48A8-B1B2-D7304EB72AF4Q38675911-174FED8A-FA50-4290-A778-623CD59FD3EEQ38676257-2CFDCF65-8605-4146-A1B9-668200B721F2Q38798845-54FC3D39-D1F2-4D2D-9910-2BC471B1BFB8Q38859044-E8AE1B25-1F86-41B3-B446-9F87A8087F2BQ39008629-C659E5C3-C3B0-41C7-875E-771E83DDF83AQ39253589-DA56EC4D-8C06-404A-AD48-BFED3FE85B28Q42347122-1A653955-202A-4789-9480-70C5C0636D6FQ42695154-0E03E9FE-B488-476B-8FCA-5A87B5831BB3Q45067817-DEB5DD8E-150E-476C-B202-0006C34F86E6Q45711780-19C8ADFC-4FC7-4654-B9AD-203D664A638BQ47245103-CC5E6E2F-9D1A-4564-8DF1-B2263A4F71F5Q47260793-C67B5DAD-72D9-4161-83A2-86A671EFFBF3Q47307583-993E7760-6724-427D-84DA-86C80997B3AAQ47436758-B1CE2FB5-BB69-4A83-B98C-C9CC493E5A67Q47581786-135095F2-FC34-414F-9492-613ABBE32E3AQ47744258-DC1C8071-19BE-45E3-B1B1-9181284AEEF7Q47779219-5CCA0F8D-3ED3-4B25-89A7-0A7A86026EC4Q47875169-68B23F8A-C20F-4644-9EB8-56C292A22193Q47880294-1C899244-242E-468A-BAC3-57FAF0ABAFF3Q47949339-3ADAF5FE-0A2D-4ED5-9812-B64519BBCAA7Q48133826-0FAB0398-49DE-4F4F-A00D-2CCA35220F6EQ51644415-9D12E4D6-74D3-44D3-816E-E4D27C11F264Q52323790-092B45F8-37ED-4C0D-871F-7B330628F29AQ52343879-9674C549-0C2B-4513-AB6C-6C66EAE26928Q52644448-743EA974-ECA7-4E65-B7DC-5E60AC382003Q52724124-FE85B0E0-4274-40A2-A725-A5EB77C4DDB5Q54219671-CEF6368A-B9DB-48B4-8E40-8302C5B3D6C9Q54265438-692C280C-A868-4FF9-BE81-8997F6C7C63EQ54948913-86636DAA-0AF9-47DA-B462-A975812FEDDBQ55032630-C42266ED-A1AB-4B3D-9199-242C1FCCD051Q58693431-E7C5160F-F829-4AEA-A4D5-CB7D8777E767Q58763111-617D0EE0-C723-4109-A4B6-2DBD06C616E8
P2860
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The MBOAT7-TMC4 Variant rs6417 ...... dividuals of European Descent.
@en
type
label
The MBOAT7-TMC4 Variant rs6417 ...... dividuals of European Descent.
@en
prefLabel
The MBOAT7-TMC4 Variant rs6417 ...... dividuals of European Descent.
@en
P2093
P2860
P50
P1433
P1476
The MBOAT7-TMC4 Variant rs6417 ...... dividuals of European Descent.
@en
P2093
Antonio Craxì
Arturo Pujia
Dermot F Reilly
Jose Castro-Perez
Paola Dongiovanni
Pirjo Käkelä
Rosaria Maria Pipitone
Salvatore Petta
Silvia Fargion
Tiziana Montalcini
P2860
P304
1219-1230.e6
P356
10.1053/J.GASTRO.2016.01.032
P407
P50
P577
2016-02-02T00:00:00Z